IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $73,645 | -53.4% | 11,525 | -30.1% | 0.06% | -68.4% |
Q3 2022 | $158,000 | -37.3% | 16,485 | -27.7% | 0.19% | -18.9% |
Q2 2022 | $252,000 | -38.1% | 22,795 | -6.8% | 0.24% | +35.2% |
Q1 2022 | $407,000 | +28.0% | 24,458 | +46.6% | 0.18% | +24.8% |
Q4 2021 | $318,000 | – | 16,684 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |